头颈癌的分子生物学：风险与途径
Molecular biology of head and neck cancer: risks and pathways.
作者信息
Stadler Michael E, Patel Mihir R, Couch Marion E, Hayes David Neil
机构信息
Department of Otolaryngology-Head & Neck Surgery, University of North Carolina at Chapel Hill, CB #7070, Chapel Hill, NC 27599, USA.
出版信息
Hematol Oncol Clin North Am. 2008 Dec;22(6):1099-124, vii. doi: 10.1016/j.hoc.2008.08.007.
Abstract
Patients present with a differential baseline risk of cancer based on normal and expected variations in genes associated with cancer. The baseline risk of developing cancer is acted on throughout life as the genome of different cells interacts with the environment in the form of exposures (eg, toxins, infections). As genetic damage is incurred throughout a lifetime (directly to DNA sequences or to the epigenome), events are set in motion to progressively disrupt normal cellular pathways toward tumorigenesis. This article attempts to characterize broad categories of genetic aberrations and pathways in a manner that might be useful for the clinician to understand the risk of developing cancer, the pathways that are disrupted, and the potential for molecular-based diagnostics.
摘要
基于与癌症相关基因的正常及预期变异，患者呈现出不同的癌症基线风险。随着不同细胞的基因组以暴露（如毒素、感染）的形式与环境相互作用，一生中患癌的基线风险都会受到影响。由于一生中会发生基因损伤（直接作用于DNA序列或表观基因组），一系列事件会随之启动，逐步破坏正常细胞向肿瘤发生发展的途径。本文试图以一种可能有助于临床医生理解患癌风险、被破坏的途径以及基于分子的诊断潜力的方式，对广泛的基因畸变和途径进行特征描述。
相似文献
1
Molecular biology of head and neck cancer: risks and pathways.头颈癌的分子生物学：风险与途径
Hematol Oncol Clin North Am. 2008 Dec;22(6):1099-124, vii. doi: 10.1016/j.hoc.2008.08.007.
2
Preface.前言。
Cancer Metastasis Rev. 2005 Jan;24(1):7-8. doi: 10.1007/s10555-005-5043-5.
3
Evaluation and treatment of metastatic head and neck squamous cancer of cutaneous origin.皮肤源性头颈部转移性鳞状细胞癌的评估与治疗
Adv Dermatol. 1993;8:265-75; discussion 276.
4
Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line.PTEN 沉默的头颈部鳞状细胞癌细胞系中对西妥昔单抗的细胞反应。
Int J Oncol. 2010 Dec;37(6):1555-63. doi: 10.3892/ijo_00000809.
5
Head and neck squamous cell cancers: need for an organised time-bound surveillance plan.头颈部鳞状细胞癌：需要制定有组织、有时限的监测计划。
Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1969-71. doi: 10.1007/s00405-010-1377-x. Epub 2010 Sep 11.
6
Mechanism of lymph node metastases: current concepts.
Otolaryngol Clin North Am. 1998 Aug;31(4):585-99. doi: 10.1016/s0030-6665(05)70074-8.
7
Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.催乳素受体是头颈部鳞状细胞癌患者的一个预后不良因素。
Br J Cancer. 2011 May 10;104(10):1641-8. doi: 10.1038/bjc.2011.131. Epub 2011 Apr 19.
8
The current role of imaging in head and neck cancer: a clinician's perspective.影像学在头颈癌中的当前作用：临床医生视角
Swiss Med Wkly. 2014 Sep 25;144:w14015. doi: 10.4414/smw.2014.14015. eCollection 2014.
9
Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma.与 FISH 相比，表皮生长因子定量蛋白表达对头颈部鳞状细胞癌的预后价值比较。
Clin Cancer Res. 2011 May 1;17(9):2947-54. doi: 10.1158/1078-0432.CCR-10-2040. Epub 2011 Feb 25.
10
Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.理解头颈部鳞状细胞癌中癌症干细胞（CSC）生物学的意义。
Oral Oncol. 2011 Apr;47(4):237-43. doi: 10.1016/j.oraloncology.2011.02.009. Epub 2011 Mar 5.
引用本文的文献
1
Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival.口腔、喉和口咽解剖区域的启动子DNA甲基化模式与肿瘤分化、淋巴结受累及生存情况相关。
Oncol Lett. 2024 Jan 8;27(3):89. doi: 10.3892/ol.2024.14223. eCollection 2024 Mar.
2
NAD pool as an antitumor target against cancer stem cells in head and neck cancer.烟酰胺腺嘌呤二核苷酸（NAD）池作为头颈部癌症肿瘤干细胞的抗肿瘤靶点。
J Exp Clin Cancer Res. 2023 Mar 3;42(1):55. doi: 10.1186/s13046-023-02631-2.
3
Metastasis and MAPK Pathways.转移和 MAPK 通路。
Int J Mol Sci. 2022 Mar 31;23(7):3847. doi: 10.3390/ijms23073847.
4
Targeting STAT3 prevents bile reflux-induced oncogenic molecular events linked to hypopharyngeal carcinogenesis.靶向 STAT3 可预防胆汁反流诱导的与下咽癌发生相关的致癌分子事件。
J Cell Mol Med. 2022 Jan;26(1):75-87. doi: 10.1111/jcmm.17011. Epub 2021 Dec 1.
5
Bile reflux and hypopharyngeal cancer (Review).胆汁反流与咽癌（综述）。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8195. Epub 2021 Sep 24.
6
Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.预测头颈部癌症预后不良的 DNA 甲基化基因的特征及其对靶向治疗的影响。
Sci Rep. 2021 May 11;11(1):10012. doi: 10.1038/s41598-021-89476-x.
7
Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal Cells.胃蛋白酶在略微酸性和中性 pH 值下促进表皮生长因子受体及其下游致癌途径在暴露的下咽细胞中的激活。
Int J Mol Sci. 2021 Apr 20;22(8):4275. doi: 10.3390/ijms22084275.
8
Comparing cell-free circulating tumor DNA mutational profiles of disease-free and nonresponders patients with oropharyngeal squamous cell carcinoma.比较口咽鳞状细胞癌无病患者和无反应患者的游离循环肿瘤DNA突变谱。
Laryngoscope Investig Otolaryngol. 2020 Sep 1;5(5):868-878. doi: 10.1002/lio2.447. eCollection 2020 Oct.
9
The temporal effects of topical NF- inhibition, in the prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model.局部NF-抑制在预防小鼠下咽黏膜胆汁相关致癌mRNA和miRNA表型中的时间效应：一项临床前模型。
Oncotarget. 2020 Sep 1;11(35):3303-3314. doi: 10.18632/oncotarget.27706.
10
Head and Neck Cancer Metastasis and the Effect of the Local Soluble Factors, from the Microenvironment, on Signalling Pathways: Is It All about the Akt?头颈癌转移以及局部微环境可溶性因子对信号通路的影响：一切都与Akt有关吗？
Cancers (Basel). 2020 Jul 28;12(8):2093. doi: 10.3390/cancers12082093.
本文引用的文献
1
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.阿昔替尼对晚期甲状腺癌的所有组织学亚型均为有效的治疗方法：一项II期研究的结果
J Clin Oncol. 2008 Oct 10;26(29):4708-13. doi: 10.1200/JCO.2007.15.9566. Epub 2008 Jun 9.
2
Head and neck cancer.头颈癌
Lancet. 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X.
3
The epithelial-mesenchymal transition generates cells with properties of stem cells.上皮-间质转化产生具有干细胞特性的细胞。
Cell. 2008 May 16;133(4):704-15. doi: 10.1016/j.cell.2008.03.027.
4
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.表皮生长因子受体（EGFR）、p16、人乳头瘤病毒（HPV）滴度、Bcl-xL和p53、性别以及吸烟作为口咽癌治疗反应和生存的指标。
J Clin Oncol. 2008 Jul 1;26(19):3128-37. doi: 10.1200/JCO.2007.12.7662. Epub 2008 May 12.
5
Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer.头颈部癌中表皮生长因子受体靶向治疗的新观点
Head Neck. 2008 May;30(5):667-74. doi: 10.1002/hed.20859.
6
EGFR antagonists in cancer treatment.癌症治疗中的表皮生长因子受体拮抗剂
N Engl J Med. 2008 Mar 13;358(11):1160-74. doi: 10.1056/NEJMra0707704.
7
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.16型人乳头瘤病毒阳性和16型人乳头瘤病毒阴性头颈癌的不同风险因素概况。
J Natl Cancer Inst. 2008 Mar 19;100(6):407-20. doi: 10.1093/jnci/djn025. Epub 2008 Mar 11.
8
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer.PI3-K/AKT通路的激活及其在头颈癌放射抵抗机制中的意义
Lancet Oncol. 2008 Mar;9(3):288-96. doi: 10.1016/S1470-2045(08)70073-1.
9
Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary.通过细胞学检查以及原位杂交技术在宫颈转移灶细针穿刺活检中检测人乳头瘤病毒相关的鳞状细胞癌：一种用于确定隐匿性头颈部原发灶部位的工具。
Cancer. 2008 Apr 25;114(2):118-23. doi: 10.1002/cncr.23348.
10
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.美国与人乳头瘤病毒相关及不相关的口腔鳞状细胞癌的发病率趋势。
J Clin Oncol. 2008 Feb 1;26(4):612-9. doi: 10.1200/JCO.2007.14.1713.
Zotero 插件